Stocktoria
Canton Strategic Holdings, Inc. CNTN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-01-12
Canton Strategic Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $3.1M | $6.4M | $3.6M | $2.3M | $1.8M |
| Operating income | -$20.1M | -$12.4M | -$9.5M | -$6.9M | -$3.2M |
| Interest expense | — | — | $16,505 | $1.6M | $831,277 |
| Income tax | -$6.2M | — | $0 | $0 | — |
| Net income | -$35.9M | -$12.2M | -$9.3M | -$8.5M | -$2.2M |
| EPS (diluted) | $-1.12 | $-9.41 | $-107.02 | $-18.72 | — |
| Operating cash flow | -$16.1M | -$10.9M | -$7.3M | -$6.6M | -$1.1M |
| Cash & equivalents | — | $3.6M | $10.9M | $6.5M | — |
| Total assets | $519.1M | $3.7M | $10.9M | $6.7M | $621,677 |
| Total liabilities | $121.2M | $2.4M | $1.8M | $1.1M | $5.3M |
| Shareholders' equity | $397.9M | $1.3M | $9.1M | $5.5M | -$4.7M |
Source: SEC EDGAR filings · CIK 0001861657 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.